Abstract
We report the emergence of an influenza virus A/H3N2-E119V neuraminidase variant from an elderly patient with renal dysfunction who received a suboptimal dose of oseltamivir prophylaxis. In neuraminidase inhibition assays, the E119V variant showed a 413-fold increase in the 50% inhibitory oseltamivir concentration and grew at titers comparable to those of the wild type in vitro.Copyright © 2013, American Society for Microbiology. All Rights Reserved.
Cite
CITATION STYLE
Roussy, J. F., Abed, Y., Bouhy, X., & Boivin, G. (2013). Emergence of an oseltamivir-resistant influenza A/H3N2 Virus in an elderly patient receiving a suboptimal dose of antiviral prophylaxis. Journal of Clinical Microbiology, 51(12), 4234–4236. https://doi.org/10.1128/JCM.02659-13
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.